How has been the historical performance of Zota Health Care?

Aug 08 2025 10:53 PM IST
share
Share Via
Zota Health Care has experienced significant revenue growth from 85.63 Cr in March 2019 to 292.97 Cr in March 2025, but has faced increasing expenditures, resulting in negative operating profit and escalating losses, with a profit after tax of -56.74 Cr in March 2025. The company also reported negative cash flow from operating activities, indicating ongoing financial challenges.
Answer:
The historical performance of Zota Health Care shows significant fluctuations in revenue and profitability over the years, culminating in a challenging fiscal year ending March 2025.

Breakdown:
Zota Health Care's net sales have shown a consistent upward trend, increasing from 85.63 Cr in March 2019 to 292.97 Cr in March 2025. However, despite this growth in revenue, the company has faced increasing total expenditures, which rose from 77.89 Cr in March 2019 to 298.70 Cr in March 2025, leading to an operating profit (PBDIT) that turned negative at -5.73 Cr in March 2025, down from a positive 9.30 Cr in March 2023. The company's profit before tax also deteriorated significantly, moving from a profit of 7.86 Cr in March 2019 to a loss of 57.64 Cr in March 2025. Consequently, the profit after tax reflected a similar trend, with losses escalating to -56.74 Cr in March 2025 compared to a profit of 8.91 Cr in March 2022. The company's total assets increased to 223.93 Cr in March 2024, up from 89.61 Cr in March 2019, while total liabilities also rose to 223.93 Cr in March 2024, indicating a growing debt level. Cash flow from operating activities has been negative in recent years, with -5.00 Cr reported in March 2024, reflecting ongoing operational challenges. Overall, while Zota Health Care has expanded its revenue base, it has struggled with profitability and cash flow management in recent years.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News